Mike Ralston, CEO of Blencowe Resources, explains the significance of the MSP for Orom-Cross. Watch the interview here.

Less Ads, More Data, More Tools Register for FREE
Sponsored Content
Sponsored Content

Pin to quick picksSeed Regulatory News (SEED)

Share Price Information for Seed (SEED)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.60
Bid: 1.50
Ask: 1.70
Change: 0.00 (0.00%)
Spread: 0.20 (13.333%)
Open: 1.60
High: 1.60
Low: 1.60
Prev. Close: 1.60

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Investee Company Update: Little Green Pharma Ltd

20 Feb 2024 16:00

RNS Number : 8136D
Seed Innovations Limited
20 February 2024

20 February 2024

SEED Innovations Limited

("SEED" or the "Company")

Investee Company Update: Little Green Pharma Ltd

SEED Innovations Ltd, the AIM-quoted investment company with a portfolio of disruptive, high-growth life sciences and technology companies, notes that portfolio company, Little Green Pharma Ltd ('LGP') has announced that the demerger of its wholly owned subsidiary, Reset, announced on 13 November 2023 is no longer proceeding and it shall remain as a subsidiary of LGP for the time being.

This is disappointing given SEED wished to invest in Reset following the demerger. Seed was unable to agree in the timeframe available with the relevant authorities in the UK whether Reset's proposed expansion into Psychedelic Assisted Psychotherapy ("PAP"), and which was legalised in Australia in July 2023 (see RNS of 6 February 2023), is permissible under the UK Proceeds of Crime Act ("POCA"). The Company had been advised by a leading KC that holding an interest in Reset on this basis did not breach POCA.

LGPs announcement in full can be accessed from the following link: www.investlittlegreenpharma.com/site/showdownloaddoc

The Company will continue to work with LGP's management, and other industry participants, to lobby regulators and Government in the UK for clarity regarding the use of psychedelic compounds outside of clinical trials in the UK in the future, supporting companies develop treatment options to UK patients suffering from a range of conditions including treatment resistant depression and PTSD. In the meantime, the Board of SEED will continue to carefully monitor the activities of LGP to ensure that SEED can continue to comply with its legal and regulatory obligations.

The Company owns 7,324,796 ordinary shares in LGP representing 2.44% of LGP's issued share capital.

- Ends -

For further information on the Company please visit:?www.seedinnovations.co£or contact:

Ed McDermott

Lance de Jersey

SEED Innovations Ltd

E: info@seedinnovations.co

James Biddle

Roland Cornish

Beaumont Cornish Limited

Nomad

T: (0)20 7628 3396

Isabella Pierre

Damon Heath

Shard Capital Partners LLP

Broker

T: (0)20 7186 9927

Ana Ribeiro

Isabel de Salis

Isabelle Morris

St Brides Partners Ltd

Financial PR

E: seed@stbridespartners.co.uk

Notes

Seed Innovations Ltd

SEED Innovations Ltd is an AIM-quoted investment company providing shareholders with exposure to disruptive, high-growth life sciences and technology companies to which in normal circumstances they would have limited access. Its strategy is to identify early-stage opportunities that have upcoming investment catalysts and grow the value of its portfolio. To this end, it currently has eight active investments with a balance of liquid, pre-liquidity, and longer-term opportunities and is well positioned to move quickly on other investment opportunities.

Little Green Pharma

Little Green Pharma is a global, vertically integrated, and geographically diverse medicinal cannabis business with operations from cultivation and production through to manufacturing and distribution.

The company has two global production sites for the manufacture of its own-branded and white-label ranges of GMP-grade medicinal cannabis products, being a 21,500m2 cultivation and 4,000m2 GMP manufacturing facility capable of producing over 30 tonnes of medicinal cannabis biomass per annum located in Denmark (EU) and an indoor cultivation and manufacturing facility located in Western Australia capable of producing ~3 tonnes of medicinal cannabis biomass per annum.

Little Green Pharma products comply with all required Danish Medicines Agency and Therapeutic Goods Administration regulations and testing requirements. With a growing range of products containing differing ratios of active ingredients, Little Green Pharma supplies medical-grade cannabis products to Australian, European, and overseas markets.

The company has a strong focus on patient access in the emerging global medicinal cannabis market and is actively engaged in promoting education and outreach programs, as well as participating in clinical investigations and research projects to develop innovative new delivery systems.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
MSCPPUUWPUPCGAU
Date   Source Headline
8th Oct 20247:24 amRNSPortfolio Update
24th Sep 20247:00 amRNSAGM Statement
2nd Sep 202412:35 pmRNSDirector/PDMR Shareholding
29th Aug 20247:00 amRNSNotice of AGM
29th Aug 20247:00 amRNSDirector Share Purchase
16th Aug 20242:55 pmRNSChange of Registered Address
7th Aug 202411:40 amRNSNew Investment: Pantheon Resources plc
30th Jul 20242:39 pmRNSHolding(s) in Company
23rd Jul 20247:00 amRNSInvestee Company Update: Little Green Pharma Ltd
19th Jun 20247:00 amRNSFinal Results
5th Jun 20247:00 amRNSCompletion of share buy-back programme
31st May 20245:29 pmRNSInvestee Company Update: Little Green Pharma Ltd
30th May 20244:34 pmRNSTransaction in Own Shares & TVR
28th May 20247:00 amRNSTransaction in Own Shares
24th May 20247:00 amRNSTransaction in Own Shares
23rd May 20247:00 amRNSTransaction in Own Shares & TVR
22nd May 202411:51 amRNSTransaction in Own Shares & TVR
21st May 20247:00 amRNSTransaction in Own Shares & TVR
20th May 20247:00 amRNSTransaction in Own Shares & TVR
17th May 20247:00 amRNSTransaction in Own Shares
16th May 20247:00 amRNSTransaction in Own Shares & TVR
14th May 202412:52 pmRNSTransaction in Own Shares
13th May 20241:51 pmRNSTransaction in Own Shares
13th May 20247:00 amRNSTransaction in Own Shares
10th May 20247:00 amRNSTransaction in Own Shares & TVR
3rd May 20244:06 pmRNSTransaction in Own Shares & TVR
3rd May 20247:00 amRNSTransaction in Own Shares & TVR
1st May 20247:00 amRNSTransaction in Own Shares
30th Apr 20247:00 amRNSTransaction in Own Shares & TVR
26th Apr 20244:46 pmRNSTransaction in Own Shares
25th Apr 202411:03 amRNSTransaction in Own Shares
24th Apr 20243:14 pmRNSTransaction in Own Shares & TVR
23rd Apr 202411:11 amRNSTransaction in Own Shares
22nd Apr 202411:33 amRNSTransaction in Own Shares
19th Apr 202410:55 amRNSTransaction in Own Shares & TVR
18th Apr 20241:20 pmRNSTransaction in Own Shares
17th Apr 20242:57 pmRNSInvestee Company Update: Little Green Pharma Ltd
17th Apr 202411:55 amRNSTransaction in Own Shares & TVR
16th Apr 20247:00 amRNSSpecial Dividend Declaration
15th Apr 20243:20 pmRNSTransaction in Own Shares
15th Apr 20247:00 amRNSTransaction in Own Shares
15th Apr 20247:00 amRNSReceipt of remaining £2.4m from sale of Leap
12th Apr 20247:00 amRNSTransaction in Own Shares & TVR
9th Apr 20241:00 pmRNSInvestee Company Update: Northern Leaf plc
8th Apr 202412:20 pmRNSTransaction in Own Shares & TVR
5th Apr 20248:25 amRNSTransaction in Own Shares
3rd Apr 20247:00 amRNSTransaction in Own Shares
27th Mar 20243:34 pmRNSTransaction in Own Shares & TVR
26th Mar 20241:03 pmRNSTransaction in Own Shares
26th Mar 20247:48 amRNSInvestee Company Update: Clean Food Group

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Free Investment Tools

Register for FREE

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.